Determinants of HIV Outpatient Service Utilization: A Systematic Review

AIDS and Behavior

Volumn 19, Issue 1, 2015, Pages 104-119

  Brennan, Aline ^a   Morley, Deirdre ^b   O’Leary, Aisling C ^c   Bergin, Colm J ^c   Horgan, Mary ^b,d  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Department of Medicine National University of Ireland Cork   (Ireland)

^c ST JAMES S HOSPITAL   (Ireland)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Ambulatory care; Health care utilization; HIV; Review

Indexed keywords

AMBULATORY CARE; ATTITUDE TO HEALTH; CD4 LYMPHOCYTE COUNT; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; OUTPATIENT DEPARTMENT; UTILIZATION;

AMBULATORY CARE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; OUTPATIENT CLINICS, HOSPITAL;

EID: 84927564695     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-014-0814-z     Document Type: Article

References (50)

1. van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS (London, England). 2010;24:1527–35.
2. Nakagawa F, Lodwick RK, Smith CJ, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS (London, England). 2012;26:335–43.
3. Giordano TP, Gifford AL, White AC, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44:1493–9.
4. Asboe D, Aitken C, Boffito M, et al (2011) British HIV association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals. BHIVA.
5. European AIDS Clinical Society. Guidelines version. 2011;6:2011.
6. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-Infected adults and adolescents. Department of Health and Human Services. 2012.
7. Sayana S, Javanbakht M, Weinstein M, Khanlou H. Clinical impact and cost of laboratory monitoring need review even in resource-rich setting. J AIDS J Acquir Immune Defic Syndr. 2011;56(3):e97–8. doi:10.1097/QAI.1090b1013e31820472e31820478.
8. Buclin T, Telenti A, Perera R, et al. Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy. PLoS One. 2011;6(4):e18578.
9. Health Resources and Services Administration. HIV AIDS Bureau Performance Measures. http://hab.hrsa.gov/deliverhivaidscare/habperformmeasures.html (2013). Accessed 18 March 2014.
10. Andersen RM. A behavioral model of families’ use of health services. Research Series No. 25. Center for Health Administration Studies, University of Chicago. 1968.
11. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10.
12. Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen’s behavioral model of health services use: a systematic review of studies from 1998–2011. Psycho-soc Med. 2012;9:Doc11.
13. Treanor C, Donnelly M. An international review of the patterns and determinants of health service utilisation by adult cancer survivors. BMC Health Serv Res. 2012;12:316.
14. McCusker J, Karp I, Cardin S, Durand P, Morin J. Determinants of emergency department visits by older adults: a systematic review. Acad Emerg Med. 2003;10(12):1362–70.
15. deBoer A, Wijker W, deHaes H. Predictors of health care utilization in the chronically ill: a review of the literature. Health Policy. 1997;42(2):101–15.
16. Uphold CR, Mkanta WN. Review: use of health care services among persons living with HIV infection: state of the science and future directions. AIDS Patient Care STDS. 2005;19(8):473–85.
17. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS (London, England). 2010;24:2665–78.
18. Beck EJ, Harling G, Gerbase S, DeLay P. The cost of treatment and care for people living with HIV infection: implications of published studies, 1999–2008. Curr Opin HIV AIDS. 2010;5(3):215–24.
19. Car LT, Brusamento S, Elmoniry H, et al. The uptake of integrated perinatal prevention of mother-to-child HIV transmission programs in low- and middle-income countries: a systematic review. PLoS One. 2013;8(3):e56550.
20. Centre for Reviews and Dissemination. Systematic reviews CRDs guidance for undertaking reviews in healthcare. York: CRD University of York; 2009.
21. The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011): The Cochrane Collaboration; 2011.
22. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
23. Gelberg L, Andersen RM, Leake BD. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302.
24. Fleishman JA, Gebo KA, Reilly ED, et al. Hospital and outpatient health services utilization among HIV-infected adults in care 2000–2002. Med Care. 2005;43(9):III40–52.
25. Siddiqui J, Phillips AL, Freedland ES, Sklar AR, Darkow T, Harley CR. Prevalence and cost of HIV-associated weight loss in a managed care population. Curr Med Res Opin. 2009;25(5):1307–17.
26. Wilson LE, Korthuis T, Fleishman JA, et al. HIV-related medical service use by rural/urban residents: a multistate perspective. AIDS Care. 2011;23(8):971–9.
27. Howe CJ, Cole SR, Napravnik S, Eron JJ. Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001–2007. AIDS Res Hum Retroviruses. 2010;26(8):875–81.
28. Velasco M, Castilla V, Guijarro C, Moreno L, Barba R, Losa JE. Differences in the use of health resources by Spanish and immigrant HIV-infected patients. Enferm Infecc Microbiol Clin. 2012;30(8):458–62.
29. Garattini L, Tediosi F, Di Cintio E, Yin D, Parazzini F. Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy. AIDS Care. 2001;13(6):733–41.
30. Cook PA, Downing J, Wheater CP, et al. Influence of socio-demographic factors on distances travelled to access HIV services: enhanced surveillance of HIV patients in North West England. BMC Public Health. 2009;9:78.
31. Bikilla AD, Jerene D, Robberstad B, Lindtjorn B. Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia. Cost Eff Resour Alloc. 2009;7:6.
32. Larson BA, Bii M, Henly-Thomas S, et al. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics. J Int AIDS Soc. 2013;16(1):18026.
33. Paton NI, Chapman CAT, Sangeetha S, Mandalia S, Bellamy R, Beck EJ. Cost and cost-effectiveness of antiretroviral therapy for HIV infection in Singapore. Int J STD AIDS. 2006;17(10):699–705.
34. Motheral B, Brooks J, Clark MA, et al. A checklist for retrospective database studies—report of the ISPOR task force on retrospective databases. Value Health. 2003;6(2):90–7.
35. HIV Research Network. https://cds.johnshopkins.edu/hivrn/index.cfm. Accessed 24 Sept 2013.
36. Horstmann E, Brown J, Islam F, Buck J, Agins BD. Retaining HIV-infected patients in care: where are we? Where do we go from here? Clin Infect Dis. 2010;50(5):752–61.
37. Fleishman JA, Yehia BR, Moore RD, Korthuis PT, Gebo KA, Network HR. Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr. 2012;60:249–59.
38. Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45(12):1593–601.
39. Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV Cohort Study. Clin Infect Dis. 2011;53:1130–9.
40. National Association of People Living with HIV, National Centre in HIV Epidemiology and Clinical Research. Mapping HIV outcomes: geographical and clinical forecasts of numbers of people living with HIV in Australia. The University of New South Wales. 2011.
41. Deeken JF, Tjen ALA, Rudek MA, et al. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis. 2012;55(9):1228–35.
42. Triant VA. HIV infection and coronary heart disease: an intersection of epidemics. J Infect Dis. 2012;205(Suppl 3):S355–61.
43. Miro JM, Cofan F, Trullas JC, et al. Renal dysfunction in the setting of HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(3):187–99.
44. Norman SP, Kommareddi M, Kaul DR. Update on kidney transplantation in HIV-infected recipients. AIDS Rev. 2012;14(3):195–207.
45. Joshi D, O’Grady J, Taylor C, Heaton N, Agarwal K. Liver transplantation in human immunodeficiency virus-positive patients. Liver Transpl. 2011;17(8):881–90.
46. Kearney F, Moore AR, Donegan CF, Lambert J. The ageing of HIV: implications for geriatric medicine. Age Ageing. 2010;39(5):536–41.
47. Abraham JM. How might the affordable care act’s coverage expansion provisions influence demand for medical care? Milbank Q. 2014;92(1):63–87.
48. United Nations Department of Economic and Social Affairs Population Division. World urbanization prospects, the 2011 revision. http://esa.un.org/unpd/wup/index.htm (2011). Accessed 27 March 2014.
49. Mandalia S, Mandalia R, Lo G, et al. Rising population cost for treating people living with HIV in the UK, 1997–2013. PLoS One. 2010;5(12):e15677.
50. Stover J, Korenromp EL, Blakley M, et al. Long-term costs and health impact of continued global fund support for antiretroviral therapy. PLoS One. 2011;6(6):e21048.